| P2093 | author name string | Muna Aryal | |
| | Zhenbo Huang | |
| | Raag D Airan | |
| | Daivik B Vyas | |
| | Sunmee Park | |
| | Niloufar Hosseini-Nassab | |
| | Jeffrey B Wang | |
| | Tommaso Di Ianni | |
| P2860 | cites work | First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease | Q22001071 |
| | The blood-brain barrier: bottleneck in brain drug development | Q22336985 |
| | Molecular determinants of blood-brain barrier permeation | Q26797482 |
| | Astrocyte-endothelial interactions at the blood-brain barrier | Q28131675 |
| | The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice | Q28253117 |
| | Neurological complications of psychiatric drugs: clinical features and management | Q28262051 |
| | The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound | Q28269056 |
| | A pilot study of focused ultrasound thalamotomy for essential tremor | Q28296521 |
| | Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications | Q28297458 |
| | Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring | Q28483970 |
| | Thermal effects of focused ultrasound on the brain: determination with MR imaging | Q48676707 |
| | Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model | Q48685009 |
| | Keyhole acceleration for magnetic resonance acoustic radiation force imaging (MR ARFI). | Q48924984 |
| | Functional ultrasound imaging of the brain | Q49096031 |
| | A dual-mode hemispherical sparse array for three-dimensional passive acoustic mapping and skull localization within a clinical MRI guided focused ultrasound device. | Q49832195 |
| | Power cavitation-guided blood-brain barrier opening with focused ultrasound and microbubbles | Q49852870 |
| | Nanomedicine safety in preclinical and clinical development: focus on idiosyncratic injection/infusion reactions | Q49953663 |
| | Temporal and spatial detection of HIFU-induced inertial and hot-vapor cavitation with a diagnostic ultrasound system | Q50248198 |
| | High-intensity focused ultrasound in the treatment of solid tumours | Q50250147 |
| | Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles | Q50250294 |
| | Optimization of spoiled gradient-echo phase imaging for in vivo localization of a focused ultrasound beam | Q50253006 |
| | Passive cavitation mapping for localization and tracking of bubble dynamics. | Q50693504 |
| | Correlation between inertial cavitation dose and endothelial cell damage in vivo. | Q51117834 |
| | The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States. | Q52596402 |
| | Blood-Brain Barrier: From Physiology to Disease and Back | Q57023036 |
| | MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain | Q57116018 |
| | Drug transport across the blood-brain barrier | Q57677287 |
| | Roadmap and strategy for overcoming infusion reactions to nanomedicines | Q57804828 |
| | Noninvasive Ultrasonic Drug Uncaging Maps Whole-Brain Functional Networks | Q58600106 |
| | Acoustically targeted chemogenetics for the non-invasive control of neural circuits | Q59968531 |
| | Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound | Q61135580 |
| | Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study | Q61445180 |
| | Clinical Trials of Thermosensitive Nanomaterials: An Overview | Q64250301 |
| | Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson's disease | Q64764725 |
| | Spinal Cord Penetration of Intrathecally Administered Cytarabine and Methotrexate: A Quantitative Autoradiographic Study | Q68509144 |
| | Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin | Q72061230 |
| | Vasospasm after subarachnoid hemorrhage: interest in diffusion-weighted MR imaging | Q74312811 |
| | Perflenapent emulsion: a US contrast agent for diagnostic radiology--multicenter, double-blind comparison with a placebo. EchoGen Contrast Ultrasound Study Group | Q74606275 |
| | Precision high intensity focusing ultrasonic machines for surgery | Q77186442 |
| | Ambient pressure dependence of the ultra-harmonic response from contrast microbubbles | Q84409544 |
| | Imaging with ultrasound contrast agents: current status and future | Q87972754 |
| | Advances in acoustic monitoring and control of focused ultrasound-mediated increases in blood-brain barrier permeability | Q90209485 |
| | First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound | Q90317315 |
| | Localized anesthesia of a specific brain region using ultrasound-responsive barbiturate nanodroplets | Q90481629 |
| | Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction | Q91046010 |
| | Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion catheters | Q92892183 |
| | Submicron-bubble-enhanced focused ultrasound for blood-brain barrier disruption and improved CNS drug delivery | Q28538441 |
| | Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system | Q28539271 |
| | Predicting variation in subject thermal response during transcranial magnetic resonance guided focused ultrasound surgery: Comparison in seventeen subject datasets | Q30276015 |
| | A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor | Q30276072 |
| | Treatment envelope evaluation in transcranial magnetic resonance-guided focused ultrasound utilizing 3D MR thermometry | Q30303060 |
| | Transcranial MRI-Guided Focused Ultrasound: A Review of the Technologic and Neurologic Applications | Q30361963 |
| | Opening the Blood-Brain Barrier with MR Imaging-guided Focused Ultrasound: Preclinical Testing on a Trans-Human Skull Porcine Model. | Q30367034 |
| | Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier opening | Q30368351 |
| | Focused Ultrasound-Induced Blood-Brain Barrier Opening: Association with Mechanical Index and Cavitation Index Analyzed by Dynamic Contrast-Enhanced Magnetic-Resonance Imaging | Q30374237 |
| | Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior | Q30402133 |
| | Transcranial phase aberration correction using beam simulations and MR-ARFI. | Q30407796 |
| | The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure | Q30407897 |
| | Gauging the likelihood of stable cavitation from ultrasound contrast agents | Q30409299 |
| | Long-Term Safety of Repeated Blood-Brain Barrier Opening via Focused Ultrasound with Microbubbles in Non-Human Primates Performing a Cognitive Task | Q30412260 |
| | Microbubble type and distribution dependence of focused ultrasound-induced blood-brain barrier opening | Q30422150 |
| | Nonthermal ablation with microbubble-enhanced focused ultrasound close to the optic tract without affecting nerve function | Q30427191 |
| | Combined ultrasound and MR imaging to guide focused ultrasound therapies in the brain | Q30434541 |
| | Rapid MR-ARFI method for focal spot localization during focused ultrasound therapy | Q30434784 |
| | Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model | Q30435074 |
| | Ultrasound-induced blood-brain barrier opening | Q30437732 |
| | Adapting MRI acoustic radiation force imaging for in vivo human brain focused ultrasound applications | Q30438309 |
| | MRI-guided focused ultrasound surgery | Q30439347 |
| | In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice | Q30439400 |
| | Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. | Q30441159 |
| | Microbubble cavitation imaging. | Q30443808 |
| | Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer | Q30450131 |
| | Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques | Q30452238 |
| | Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller | Q30455962 |
| | MR-guided adaptive focusing of therapeutic ultrasound beams in the human head | Q30458729 |
| | Noninvasive photoacoustic computed tomography of mouse brain metabolism in vivo | Q30459610 |
| | Combined passive detection and ultrafast active imaging of cavitation events induced by short pulses of high-intensity ultrasound | Q30467635 |
| | Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier | Q30472787 |
| | Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion | Q30474693 |
| | Blood-brain barrier: interface between internal medicine and the brain | Q39448152 |
| | Blood-brain barrier-specific properties of a human adult brain endothelial cell line | Q40377619 |
| | Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier | Q42153590 |
| | Controlled vesicle deformation and lysis by single oscillating bubbles | Q44433762 |
| | Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas | Q45325311 |
| | Simultaneous MR thermometry and acoustic radiation force imaging using interleaved acquisition | Q46736461 |
| | Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging | Q46768075 |
| | MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits | Q46802417 |
| | Neuromodulation with nanoparticles | Q47267027 |
| | Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time | Q47271745 |
| | Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model | Q47352783 |
| | Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders | Q47707801 |
| | Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging. | Q47875953 |
| | MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study | Q48113723 |
| | Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice | Q48327685 |
| | Poor drug distribution as a possible explanation for the results of the PRECISE trial | Q48374857 |
| | Microbubble contrast agent with focused ultrasound to create brain lesions at low power levels: MR imaging and histologic study in rabbits | Q48415838 |
| | Correlation of ultrasound phase with physical skull properties | Q48571140 |
| | Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity | Q48655725 |
| | Clinical trial of blood-brain barrier disruption by pulsed ultrasound | Q48674887 |
| | MR-guided adaptive focusing of ultrasound | Q30476369 |
| | MR-guided transcranial brain HIFU in small animal models | Q30476911 |
| | Passive cavitation imaging with ultrasound arrays | Q30478402 |
| | Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles | Q30479575 |
| | Magnetic resonance acoustic radiation force imaging | Q30487830 |
| | Ultrasound for drug and gene delivery to the brain | Q30488675 |
| | Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption | Q30500905 |
| | Quantitative MRI-based temperature mapping based on the proton resonant frequency shift: review of validation studies | Q31003584 |
| | Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles | Q33375795 |
| | Ultrasound focusing using magnetic resonance acoustic radiation force imaging: application to ultrasound transcranial therapy | Q33633257 |
| | Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy | Q33770621 |
| | Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery | Q33946973 |
| | Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits | Q33954300 |
| | Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound | Q33992793 |
| | Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model | Q34043432 |
| | Seizure-promoting effect of blood-brain barrier disruption | Q34056074 |
| | Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival | Q34260206 |
| | Architectonic Mapping of the Human Brain beyond Brodmann | Q34505906 |
| | New targets for rapid antidepressant action | Q34507177 |
| | Computational approaches to the prediction of the blood-brain distribution | Q34581548 |
| | Calibrated functional MRI: mapping the dynamics of oxidative metabolism | Q35892841 |
| | MR thermometry | Q37064971 |
| | Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy | Q37301832 |
| | Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia | Q37358657 |
| | Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation. | Q37577170 |
| | Noninvasive Targeted Transcranial Neuromodulation via Focused Ultrasound Gated Drug Release from Nanoemulsions | Q37716093 |
| | Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound | Q37725032 |
| | The role of Gliadel wafers in the treatment of high-grade gliomas | Q38162925 |
| | Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model. | Q38767820 |
| | A multi-frequency sparse hemispherical ultrasound phased array for microbubble-mediated transcranial therapy and simultaneous cavitation mapping | Q38795258 |
| | Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery | Q38864446 |
| | Quantitative Frequency-Domain Passive Cavitation Imaging. | Q39004688 |
| | Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery. | Q39169262 |
| | Design and experimental evaluation of a 256-channel dual-frequency ultrasound phased-array system for transcranial blood-brain barrier opening and brain drug delivery | Q39225011 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 675 | |
| P577 | publication date | 2020-07-14 | |
| P1433 | published in | Frontiers in Neuroscience | Q2177807 |
| P1476 | title | Focused Ultrasound for Noninvasive, Focal Pharmacologic Neurointervention | |
| P478 | volume | 14 | |